Feb 14 (Reuters) - Indian auto-parts maker Samvardhana Motherson (SAMD.NS), opens new tab reported a smaller-than-expected rise in third-quarter profit on Friday, hurt by weak global car sales.

Huma Therapeutics has been granted Class II clearance from the FDA for its Software-as-a-Medical-Device (SaMD) disease management platform, dramatically expanding the range of services it can deliver.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Commercial opportunities for businesses developing and deploying artificial intelligence (AI) systems, as well as for those building the infrastructure to underpin AI use, will emerge from the ‘pro AI ...